Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of P28GST Treatment in Crohn's Disease Patients, a Multicenter Phase 2 Clinical Trial

NCT02281916 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT02281916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02281916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of P28GST Treatment in Crohn's Disease Patients, a Multicenter Phase 2 Clinical Trial
Lead sponsor
University Hospital, Lille
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2014
Completion date
February 28, 2018
Enrollment
10 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's ileocolitis